p38/SAPK2 Inhibitor (SB 202190)

Potent inhibitor of p38 alpha/SAPK2a and p38 beta/SAPK2b kinases.

The p38/SAPK2 Inhibitor (SB 202190) controls the biological activity of p38/SAPK2. This small molecule/inhibitor is primarily used for Biochemicals applications.

Inhibitor Type: Kinase

Protein Target: p38/SAPK2

Target Sub-Family: CMGC

C₂0H₁₄FN₃O

3 years at -20°C

Routinely evaluated in a kinase assay as an inhibitor.

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.